Literature DB >> 7890394

Identification of an immunologically important hypervariable domain of major outer surface protein A of Borrelia burgdorferi.

B C McGrath1, J J Dunn, G Gorgone, D Guttman, D Dykhuizen, B J Luft.   

Abstract

The gene for the major outer surface protein A (OspA) from several clinically obtained strains of Borrelia burgdorferi, the cause of Lyme disease, has been cloned, sequenced, and expressed in Escherichia coli by using a T7-based expression system (J. J. Dunn, B. N. Lade, and A. G. Barbour, Protein Expr. Purif. 1:159-168, 1990). All of the OspAs have a single conserved tryptophan at residue 216 or, in some cases, 217; however, the region of the protein flanking the tryptophan is hypervariable, as determined by a moving-window population analysis of ospA from 15 European and North American isolates of B. burgdorferi. Epitope-mapping studies using chemically cleaved OspA and a TrpE-OspA fusion have indicated that this hypervariable region is important for immune recognition. Biophysical analysis, including fluorescence and circular dichroism spectroscopy, have indicated that the conserved tryptophan is buried in a hydrophobic environment. Polar amino acid side chains flanking the tryptophan are likely to be exposed to the hydrophilic solvent. The hypervariability of these solvent-exposed amino acid residues may contribute to the antigenic variation in OspA. To test this, we have performed site-directed mutagenesis to replace some of the potentially exposed amino acid side chains in the B31 protein with the analogous residues of a Borrelia garinii strain, K48. The altered proteins were then analyzed by Western blot (immunoblot) with monoclonal antibodies which bind OspA on the surface of the intact B31 spirochete. Our results indicate that specific amino acid changes near the tryptophan can abolish the reactivity of OspA to these monoclonal antibodies, which is an important consideration in the design of vaccines based on recombinant OspA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7890394      PMCID: PMC173158          DOI: 10.1128/iai.63.4.1356-1361.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Protection of mice against the Lyme disease agent by immunizing with recombinant OspA.

Authors:  E Fikrig; S W Barthold; F S Kantor; R A Flavell
Journal:  Science       Date:  1990-10-26       Impact factor: 47.728

2.  Mapping antibody-binding domains of the major outer surface membrane protein (OspA) of Borrelia burgdorferi.

Authors:  W H Schubach; S Mudri; R J Dattwyler; B J Luft
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

3.  Lyme borreliosis: host responses to Borrelia burgdorferi.

Authors:  A Szczepanski; J L Benach
Journal:  Microbiol Rev       Date:  1991-03

4.  Determination of window size for analyzing DNA sequences.

Authors:  F Tajima
Journal:  J Mol Evol       Date:  1991-11       Impact factor: 2.395

5.  Use of T7 RNA polymerase to direct expression of cloned genes.

Authors:  F W Studier; A H Rosenberg; J J Dunn; J W Dubendorff
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

6.  Lyme disease spirochetes and ixodid tick spirochetes share a common surface antigenic determinant defined by a monoclonal antibody.

Authors:  A G Barbour; S L Tessier; W J Todd
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

7.  Molecular mapping of Osp-A mediated immunity against Borrelia burgdorferi, the agent of Lyme disease.

Authors:  J E Sears; E Fikrig; T Y Nakagawa; K Deponte; N Marcantonio; F S Kantor; R A Flavell
Journal:  J Immunol       Date:  1991-09-15       Impact factor: 5.422

8.  Use of N-chlorosuccinimide/urea for the selective cleavage of tryptophanyl peptide bonds in proteins. Cytochrome c.

Authors:  M A Lischwe; M T Sung
Journal:  J Biol Chem       Date:  1977-07-25       Impact factor: 5.157

9.  Recombinant outer surface protein a from Borrelia burgdorferi induces antibodies protective against spirochetal infection in mice.

Authors:  M M Simon; U E Schaible; M D Kramer; C Eckerskorn; C Museteanu; H K Müller-Hermelink; R Wallich
Journal:  J Infect Dis       Date:  1991-07       Impact factor: 5.226

Review 10.  Immunodiagnosis of Lyme borreliosis.

Authors:  R J Dattwyler; B J Luft
Journal:  Rheum Dis Clin North Am       Date:  1989-11       Impact factor: 2.670

View more
  6 in total

1.  Multiple infections of Ixodes scapularis ticks by Borrelia burgdorferi as revealed by single-strand conformation polymorphism analysis.

Authors:  D S Guttman; P W Wang; I N Wang; E M Bosler; B J Luft; D E Dykhuizen
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

2.  Characterization of an anti-Borrelia burgdorferi OspA conformational epitope by limited proteolysis of monoclonal antibody-bound antigen and mass spectrometric peptide mapping.

Authors:  V Legros; C Jolivet-Reynaud; N Battail-Poirot; C Saint-Pierre; E Forest
Journal:  Protein Sci       Date:  2000-05       Impact factor: 6.725

3.  Crystal structure of Lyme disease antigen outer surface protein A complexed with an Fab.

Authors:  H Li; J J Dunn; B J Luft; C L Lawson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

4.  Evidence of Borrelia autoimmunity-induced component of Lyme carditis and arthritis.

Authors:  Elizabeth S Raveche; Steven E Schutzer; Helen Fernandes; Helen Bateman; Brian A McCarthy; Steven P Nickell; Madeleine W Cunningham
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

5.  Agglutination of Borreliella burgdorferi by Transmission-Blocking OspA Monoclonal Antibodies and Monovalent Fab Fragments.

Authors:  Amber M Frye; Monir Ejemel; Lisa Cavacini; Yang Wang; Michael J Rudolph; Renjie Song; Nicholas J Mantis
Journal:  Infect Immun       Date:  2022-08-24       Impact factor: 3.609

6.  OspA-CD40 dyad: ligand-receptor interaction in the translocation of neuroinvasive Borrelia across the blood-brain barrier.

Authors:  Lucia Pulzova; Andrej Kovac; Rastislav Mucha; Patrik Mlynarcik; Elena Bencurova; Marian Madar; Michal Novak; Mangesh Bhide
Journal:  Sci Rep       Date:  2011-09-08       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.